James B. Adams (professor)

James Brewster Adams
Residence Phoenix, Arizona
Fields Engineering, child psychiatry
Institutions Arizona State University
Alma mater University of Wisconsin-Madison
Thesis Nucleation and growth of thin films (1987)
Known for Autism-related research
Spouse Marie Adams
Children Three

James B. Adams is a President's Professor at Arizona State University, where he directs the autism/Asperger's research program, though he originally taught chemical and materials engineering there. Adams also holds a post at the Southwest College of Naturopathic Medicine. He is also the president of the Autism Society of Greater Phoenix, the co-chair of the Autism Research Institute's scientific advisory committee, and has received the Autism Service Award from the Greater Phoenix chapter of the Autism Society of America. He has been featured on Dateline NBC,[1] and received a National Science Foundation Presidential Young Investigator Award from President George Bush.

Education

Dr. Adams has a bachelor's degree from Duke University in physics (1984), as well an MS (1986) and a PhD (1987) in materials engineering from the University of Wisconsin-Madison.[2]

Career

Adams was formerly an assistant, and later associate, professor of engineering at the University of Illinois at Urbana-Champaign from 1989 to 1996, whereupon he became an associate professor at ASU. He became a full professor in 1998.[3]

Research

Engineering

Adams' team at ASU works in the field of computational and materials science, studying semiconductor processing and the ideal coatings for tools used for aluminum processing using computer simulations, as well as silicon thin-film cells.[4]

Autism

Adams' autism-related research has concluded that it is likely that heavy metals, particularly cadmium and mercury,[5][6] are related to the etiology of autism, and has also concluded that chelation therapy,[7][8] as well as pioglitazone,[9] may be an effective way to treat it. In addition, Adams contends that elevated testosterone levels are linked to the depletion of glutathione, which in turn results in increased susceptibility to toxic metals, citing the research of Simon Baron-Cohen.[10] Adams is also on the scientific advisory board of the IAOMT.[11] Adams, in an interview with NBC News, stated that the "symptoms of Acrodynia [caused by exposure to mercury in teething powders] were pretty similar to symptoms of autism."[12] However, a paper published in Pediatrics noted that there are major differences between the symptoms of mercury poisoning and those of autism.[13] Adams' research has been described as "a laundry list of autism woo" by Emily Willingham.[14]

Personal life

Adams and his wife, Marie, have three children. He became interested in autism when his daughter, Kim, was diagnosed with the disorder in 1994;[15] he has stated he suspects this occurred because of her vaccinations and stopped vaccinating her after her autism diagnosis.[16]

Selected publications

Engineering

Autism

References

  1. ↑ http://www.neurologicalhealth.org/board-of-directors.html
  2. ↑ "James Adams". ASU. Retrieved 18 October 2013.
  3. ↑ "James B. Adams CV". Puterakembara.com. Retrieved 21 October 2013.
  4. ↑ "Research--CMS Group". Retrieved 20 October 2013.
  5. ↑ "Higher Levels of Several Toxic Metals Found in Children With Autism". ScienceDaily. 25 February 2013. Retrieved 19 October 2013.
  6. ↑ Adams, J. B.; Audhya, T.; McDonough-Means, S.; Rubin, R. A.; Quig, D.; Geis, E.; Gehn, E.; Loresto, M.; Mitchell, J.; Atwood, S.; Barnhouse, S.; Lee, W. (2012). "Toxicological Status of Children with Autism vs. Neurotypical Children and the Association with Autism Severity". Biological Trace Element Research. 151 (2): 171–180. doi:10.1007/s12011-012-9551-1. PMID 23192845.
  7. ↑ Adams, J. B.; Baral, M.; Geis, E.; Mitchell, J.; Ingram, J.; Hensley, A.; Zappia, I.; Newmark, S.; Gehn, E.; Rubin, R. A.; Mitchell, K.; Bradstreet, J.; El-Dahr, J. (2009). "Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results". BMC Clinical Pharmacology. 9: 16. doi:10.1186/1472-6904-9-16. PMC 2774660Freely accessible. PMID 19852789.
  8. ↑ Adams, J. B.; Baral, M.; Geis, E.; Mitchell, J.; Ingram, J.; Hensley, A.; Zappia, I.; Newmark, S.; Gehn, E.; Rubin, R. A.; Mitchell, K.; Bradstreet, J.; El-Dahr, J. (2009). "Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results". BMC Clinical Pharmacology. 9: 17. doi:10.1186/1472-6904-9-17. PMC 2770991Freely accessible. PMID 19852790.
  9. ↑ Boris, M.; Kaiser, C. C.; Goldblatt, A.; Elice, M. W.; Edelson, S. M.; Adams, J. B.; Feinstein, D. L. (2007). "Effect of pioglitazone treatment on behavioral symptoms in autistic children". Journal of Neuroinflammation. 4: 3. doi:10.1186/1742-2094-4-3. PMC 1781426Freely accessible. PMID 17207275.
  10. ↑ Harrell, Eben (15 January 2009). "A Link Between Autism and Testosterone?". Time. Retrieved 19 October 2013.
  11. ↑ Scientific Advisory Board
  12. ↑ Larson, John (4 June 2006). "The Unorthodox Practice of Chelation". NBC News. Retrieved 27 October 2013.
  13. ↑ Nelson, K. B.; Bauman, M. L. (2003). "Thimerosal and Autism?". Pediatrics. 111 (3): 674–679. doi:10.1542/peds.111.3.674. PMID 12612255.
  14. ↑ Willingham, Emily (4 October 2011). "If a researcher has a tie to autism, should that be disclosed in autism-research papers?". A Life Less Ordinary?. Retrieved 19 October 2013.
  15. ↑ http://autism.asu.edu/Background/Background.html
  16. ↑ "Decision to vaccinate can be major dilemma for nervous parents". Arizona Daily Star. 24 June 2012. Retrieved 19 October 2013.
This article is issued from Wikipedia - version of the 4/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.